Evaluation of pharmacist-managed diabetes mellitus under a collaborative drug therapy agreement (Q37270953)

19 August 2017

title

Evaluation of pharmacist-managed diabetes mellitus under a collaborative drug therapy agreement (English)

1 reference

19 August 2017

1 reference

Jaime P Anaya

1 reference

19 August 2017

Jose O Rivera

1 reference

19 August 2017

Ken Lawson

1 reference

19 August 2017

Jose Garcia

1 reference

19 August 2017

Jose Luna

1 reference

19 August 2017

Melchor Ortiz

1 reference

19 August 2017

publication date

1 October 2008

1 reference

American Journal of Health-System Pharmacy

19 August 2017

published in

1 reference

19 August 2017

1 reference

19 August 2017

1 reference

19 August 2017

page(s)

1841-1845

1 reference

Clinical pharmacists and inpatient medical care: a systematic review

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070568

ASHP Statement on the Role of Health-System Pharmacists in Public Health

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070568

Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070568

Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization. A randomized, controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070568

A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070568

A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070568

Collaborative Drug Therapy Management by Pharmacists—2003

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070568

Progress of pharmacist collaborative practice: status of state laws and regulations and perceived impact of collaborative practice

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070568

Survey of pharmacist collaborative drug therapy management in hospitals

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070568

Ambulatory care pharmacy services: has the agenda changed?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070568

Professional implications of the expansion of pharmacy-based medical clinics

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070568

Outcomes of pharmacist-managed diabetes care services in a community health center

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070568

Tobacco interventions delivered by pharmacists: a summary and systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070568

Promoting behavioral science research in diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070568

Management of patients with type 2 diabetes by pharmacists in primary care clinics

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070568

Evaluation of a pharmaceutical care model on diabetes management

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070568

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070568

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070568

Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk)

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070568

Effect of improved glycemic control on health care costs and utilization

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070568

31 March 2020

Identifiers

DOI

10.2146/AJHP070568

1 reference

19 August 2017

1 reference